Konrad J Werhahn Selected Research

Konrad J Werhahn Research Topics

9	Epilepsy (Aura) 01/2020 - 04/2009
7	Seizures (Absence Seizure) 12/2022 - 03/2010
6	Partial Epilepsies (Epilepsy, Partial) 12/2022 - 04/2009
3	Temporal Lobe Epilepsy 01/2015 - 08/2006
3	Stroke (Strokes) 02/2006 - 10/2003
2	Headache (Headaches) 01/2020 - 12/2017
2	Dizziness (Lightheadedness) 01/2020 - 12/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2018 - 12/2017
2	Hippocampal Sclerosis 01/2015 - 08/2006
1	Drug Resistant Epilepsy 12/2022
1	Sleepiness 01/2020
1	Neuralgia (Stump Neuralgia) 12/2017
1	Heart Diseases (Heart Disease) 12/2017
1	Nausea 12/2017
1	Juvenile Myoclonic Epilepsy 09/2010
1	Adenocarcinoma 08/2006
1	Stiff-Person Syndrome (Stiff Man Syndrome) 08/2006
1	Infections 05/2006

5	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020 - 05/2011
5	LigandsIBA 01/2015 - 08/2006
4	Carbamazepine (Tegretol)FDA LinkGeneric 10/2018 - 03/2015
4	Levetiracetam (Keppra)FDA LinkGeneric 10/2018 - 05/2011
4	Dopamine (Intropin)FDA LinkGeneric 01/2015 - 08/2006
3	fallyprideIBA 09/2010 - 08/2006
2	padsevonilIBA 12/2022 - 01/2020
2	Lamotrigine (Lamictal)FDA LinkGeneric 10/2018 - 03/2015
2	CholesterolIBA 10/2018 - 12/2017
2	Lacosamide FDA Link 12/2017 - 01/2017
1	LipidsIBA 10/2018
1	C-Reactive ProteinIBA 10/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2018
1	Lipoprotein(a)IBA 10/2018
1	Valproic Acid (Depakote)FDA LinkGeneric 08/2016
1	N- ((1- allyl- 2- pyrrolidinyl)methyl)- 5- (3- fluoropropyl)- 2,3- dimethoxybenzamideIBA 01/2015
1	brivaracetamIBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Dopamine Receptors (Dopamine Receptor)IBA 03/2010
1	Pilocarpine (Ocusert)FDA LinkGeneric 03/2010
1	Immunoglobulin E (IgE)IBA 04/2009
1	amphiphysinIBA 08/2006
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2006

1	Contraindications 03/2015
1	Therapeutics 05/2011
1	Nerve Block (Nerve Blocks) 02/2006
1	Anesthesia 08/2004
1	Transcranial Magnetic Stimulation 10/2003